YolandaTsengMD

PubMed

• 36 citations
  Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
  Yolanda D. Tseng, Yu-Hui Chen, Paul J. Catalano, Andrea K. Ng
  International Journal of Radiation Oncology, Biology, Physics. 2013-10-01
• 324 citations
  Insulin signaling meets mitochondria in metabolism
  Zhiyong Cheng, Yolanda D. Tseng, Morris F. White
  Trends in Endocrinology and Metabolism. 2010-10-01
• 31 citations
  Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
  Ryan C Lynch, Chaitra S Ujjani, Christina Poh, Edus H Warren, Stephen D Smith
  Blood. 2023-05-25

Abstracts/Posters

• Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
  Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
  Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
  Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell TherapyClinically Relevant Abstract 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018